Top Markets
#1 SSV Network SSV Network +22.92%
#2 EXOD EXOD +22.08%
#3 Derive Derive +21.36%
#4 Velvet Velvet +21.35%
#5 The Black Bull The Black Bull +21.24%
#6 XPIN Network XPIN Network +18.75%
#7 Binance-Peg Bitcoin Cash Binance-Peg Bitcoin Cash +18.45%
#8 wojak wojak +18.32%
#9 Bitcoin Cash Bitcoin Cash +18.11%
#10 Arowana Arowana +17.65%
Coin of the day
SSV Network SSV Network
Settings
Language
ENGLISH
Currency
USD
Theme
Biostage, Inc. Biostage, Inc.

Biostage, Inc.

BSTG
Rank in Stocks #24985
Biostage, Inc. is a biotechnology enterprise dedicated to developing medical... Biostage, Inc. is a biotechnology enterprise dedicated to developing medical products aimed at curing patients suffering from cancers, injuries, and congenital defects within the gastrointestinal system and respiratory pathways. A primary focus for the company is the advancement of its Biostage Esophageal Implant, specifically designed to address esophageal cancer. Founded in 2009, the organization was formerly known as Harvard Apparatus Regenerative Technology, Inc. before rebranding as Biostage, Inc. in March 2016. Its corporate headquarters are located in Holliston, Massachusetts.
Share Price
$3.95
Last synced: 2023-08-15
Market Cap
$54.45M
Change (1 day)
0.00%
Change (1 year)
0.00%
Country
US
Trade Biostage, Inc. (BSTG)

Category

Healthcare
P/E ratio for Biostage, Inc. (BSTG)
P/E ratio as of 2026 TTM: 0
According to Biostage, Inc. latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 0. At the end of 2026 the company had a P/E ratio of 0.
P/E ratio history for Biostage, Inc. from 2026 to 2026
P/E ratio at the end of each year
Year P/E Ratio Change
Not enough data for the provided dates.
P/E ratio for similar companies or competitors
Company P/E Ratio P/E Ratio Difference Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 29.20 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 30.62 -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 32.46 -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 -7.93 -
US
How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share.
A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.

Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.